DIFFUSE LARGE B-CELL LYMPHOMA STAGE I

DIFFUSE LARGE B-CELL LYMPHOMA STAGE I was reported 42 times

DIFFUSE LARGE B-CELL LYMPHOMA STAGE I is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 gamma-Aminobutyric Acid A Receptor Agonist [EPC] 1 0.0006
1 Sulfonamide Antibacterial [EPC] 1 0.0003
2 Purine Antimetabolite [EPC] 7 0.0001
3 Provitamin D2 Compound [EPC] 2 0.0001
4 Nitrofuran Antibacterial [EPC] 1 0.0001
5 Antimetabolite Immunosuppressant [EPC] 1 0.0000
6 Calcineurin Inhibitor Immunosuppressant [EPC] 5 0.0000
7 Parathyroid Hormone-Related Peptide Analog [EPC] 1 0.0000
8 Integrin Receptor Antagonist [EPC] 2 0.0000
9 beta3-Adrenergic Agonist [EPC] 1 0.0000
10 Aminosalicylate [EPC] 2 0.0000
11 Folate Analog Metabolic Inhibitor [EPC] 8 0.0000
12 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
13 Alkylating Drug [EPC] 4 0.0000
14 Vitamin D [EPC] 4 0.0000
15 Corticosteroid [EPC] 17 0.0000
16 Topoisomerase Inhibitor [EPC] 1 0.0000
17 Vitamin B12 [EPC] 4 0.0000
18 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
19 Vitamin C [EPC] 4 0.0000
20 CD20-directed Cytolytic Antibody [EPC] 3 0.0000
21 Sulfonylurea [EPC] 1 0.0000
22 Fluoroquinolone Antibacterial [EPC] 1 0.0000
23 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
24 Azole Antifungal [EPC] 1 0.0000
25 Angiotensin 2 Receptor Blocker [EPC] 2 0.0000
26 Janus Kinase Inhibitor [EPC] 1 0.0000
27 Phosphodiesterase 4 Inhibitor [EPC] 1 0.0000
28 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
29 HMG-CoA Reductase Inhibitor [EPC] 2 0.0000
30 Tumor Necrosis Factor Blocker [EPC] 5 0.0000
31 Benzodiazepine [EPC] 3 0.0000
32 Nonsteroidal Anti-inflammatory Drug [EPC] 5 0.0000
33 Platinum-based Drug [EPC] 1 0.0000
34 Kinase Inhibitor [EPC] 2 0.0000
35 Platelet Aggregation Inhibitor [EPC] 2 0.0000
36 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
37 GLP-1 Receptor Agonist [EPC] 1 0.0000
38 Loop Diuretic [EPC] 1 0.0000
39 Thalidomide Analog [EPC] 1 0.0000